Chargement en cours...
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm characterized by erythrocytosis and the presence of Janus kinase (JAK) 2V617F or similar mutations. This review summarizes the pathophysiology of PV, the challenges associated with traditional treatment options, and the scientific ratio...
Enregistré dans:
| Publié dans: | Blood Lymphat Cancer |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6467337/ https://ncbi.nlm.nih.gov/pubmed/31360077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S101185 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|